| Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases (NCT02288000) | University Hospital, Lille | 2016-09-14 |
| Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies (NCT03052712) | Centre Hospitalier Universitaire, Amiens | 2016-09-09 |
| The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease (NCT05102045) | Istanbul Medipol University Hospital | 2016-09-01 |
| Self-Directed Online Training for Chinese Caregivers (NCT03308032) | Environment and Health Group, Inc. | 2016-09-01 |
| Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO (NCT02835716) | Millennium Magnetic Technologies, LLC | 2016-09-01 |
| Therapeutic Role of Transcranial DCS in Alzheimer (NCT03313518) | Assiut University | 2016-08-12 |
| BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease. (NCT02788513) | Boehringer Ingelheim | 2016-08-11 |
| The Brain Ketone Body Challenge Imaging Study (NCT03204604) | Wake Forest University Health Sciences | 2016-08-08 |
| Telephone Versus Videoconference Communication for Remote Genetic Disclosure in the APOE4 Trial (NCT02978729) | University of Pennsylvania | 2016-08-01 |
| Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program (NCT02802371) | Hospices Civils de Lyon | 2016-08-01 |
| Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study (NCT02846415) | The Hong Kong Polytechnic University | 2016-08-01 |
| Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain (NCT03080051) | Molecular NeuroImaging | 2016-08-01 |
| I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD (NCT02874820) | Imperial College London | 2016-07-01 |
| Virtual Environment to Aid Cognitive Stimulation of Elderly People With Early Alzheimer's (NCT04919005) | University of Mogi das Cruzes | 2016-07-01 |
| Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome (NCT02854917) | NYU Langone Health | 2016-07-01 |
| HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease (NCT02638519) | Thunder Bay Regional Health Research Institute | 2016-06-27 |
| Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein (NCT03071224) | Invicro | 2016-06-01 |
| Neurologic Stem Cell Treatment Study (NCT02795052) | MD Stem Cells | 2016-06-01 |
| Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease (NCT03250741) | I.R.C.C.S. Fondazione Santa Lucia | 2016-06-01 |
| Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061) (NCT02750306) | Merck Sharp & Dohme LLC | 2016-05-23 |
| Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants (NCT02769065) | Takeda | 2016-05-05 |
| F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected (NCT03279523) | Tammie L. S. Benzinger, MD, PhD | 2016-05-03 |
| Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study (NCT02740634) | Mayo Clinic | 2016-05-01 |
| Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters (NCT03408041) | Murielle Surquin | 2016-05-01 |
| The Healthy Patterns Sleep Study (NCT03682185) | University of Pennsylvania | 2016-05-01 |
| Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans (NCT03287765) | Tammie L. S. Benzinger, MD, PhD | 2016-05-01 |
| Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease (NCT03363269) | IlDong Pharmaceutical Co Ltd | 2016-04-12 |
| Neuroinflammation and Cognitive Decline in Alzheimer Disease (NCT02377206) | University Hospital, Tours | 2016-04-06 |
| Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks (NCT03153371) | University of California, Los Angeles | 2016-04-04 |
| Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease (NCT02955706) | Dong-A ST Co., Ltd. | 2016-04-01 |
| PET Imaging of Subjects Using 124I-PU-AD (NCT03371420) | Samus Therapeutics, Inc. | 2016-04-01 |
| Optical Coherence Tomography in Cerebral Amyloidosis (NCT03472482) | Universitaire Ziekenhuizen KU Leuven | 2016-03-25 |
| Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer Disease (NCT03270137) | Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente | 2016-03-10 |
| Evaluation of the Animal Intervention Used as Therapy (NCT02829801) | Hospices Civils de Lyon | 2016-03-02 |
| Living Alone in Old Age With Cognitive Impairment (NCT03330587) | University of California, San Francisco | 2016-03-01 |
| Triggered Palliative Care for Advanced Dementia (NCT02719938) | University of North Carolina, Chapel Hill | 2016-03-01 |
| Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment (NCT02778581) | Team Foods Colombia S.A. | 2016-03-01 |
| Pragmatic Trial of Video Education in Nursing Homes (NCT02612688) | Brown University | 2016-03-01 |
| Detecting Beta-amyloid in the Retina (NCT07529912) | Center for Eye Research Australia | 2016-02-04 |
| Powerful Tools for Caregivers of Dementia Patients (NCT02697721) | Florida State University | 2016-02-01 |
| Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study (NCT02612376) | University of Colorado, Denver | 2016-02-01 |
| Identification of Proteostasis-related Biomarkers in Alzheimer´s Dementia (NCT02686554) | Charite University, Berlin, Germany | 2016-01-01 |
| A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD (NCT02624778) | Eli Lilly and Company | 2015-12-22 |
| Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease (NCT02811653) | Centre Hospitalier Universitaire, Amiens | 2015-12-16 |
| Illiteracy and Vulnerability to Alzheimer's Disease: Evaluation of Amyloid Pathology by PET Imaging (NCT02494531) | Assistance Publique - Hôpitaux de Paris | 2015-12-12 |
| Study of STA-1 as an Add-on Treatment to Donepezil (NCT01255046) | Sinphar Pharmaceutical Co., Ltd | 2015-12-01 |
| Multi-center Imaging Genetics Studies in China (NCT02681822) | Tianjin Medical University General Hospital | 2015-11-01 |
| GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype (NCT02564692) | Banner Health | 2015-11-01 |
| Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté (NCT02626377) | Centre Hospitalier Universitaire de Besancon | 2015-10-01 |
| Multiple Ascending Dose Study of ALZ-801 (NCT04157712) | Alzheon Inc. | 2015-09-26 |
| Single Dose Study of ALZ-801 Prototype Tablets (NCT04585347) | Alzheon Inc. | 2015-09-16 |
| Defining the Genetic Etiology of Alzheimer's Disease in the Faroe Islands (NCT03628404) | Faroese Hospital System | 2015-09-01 |
| Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs (NCT02253732) | Slovak Academy of Sciences | 2015-09-01 |
| Transcranial Pulse Stimulation (TPS) for Alzheimer's Disease (AD) (NCT04333329) | Storz Medical AG | 2015-08-08 |
| The COACH Project: Combined Online Assistance for Caregiver Health (NCT03123224) | Palo Alto Veterans Institute for Research | 2015-08-01 |
| Effects of Exercise on Functional Ability in People With Dementia in Nursing Homes:a Cluster Randomised Controlled Trial (NCT02444078) | University Hospital, Toulouse | 2015-08-01 |
| An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum (NCT02406027) | Janssen Research & Development, LLC | 2015-07-02 |
| A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients (NCT02648906) | Daewoong Pharmaceutical Co. LTD. | 2015-07-01 |
| Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection? (NCT02843906) | University Hospital, Grenoble | 2015-07-01 |
| Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's Disease (NCT01707719) | Raffaele Antonelli Incalzi | 2015-06-01 |
| New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders) (NCT02462291) | Universita di Verona | 2015-06-01 |
| NMDA Enhancer for the Treatment of Mild Alzheimer's Disease (NCT03752463) | Chang Gung Memorial Hospital | 2015-05-22 |
| Association Between Cerebral Arterial Vascular Flow and Sleep Apnea in Neurodegenerative Alterations (NCT02578303) | Central Hospital Saint Quentin | 2015-05-01 |
| Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging (NCT02440646) | Central Clinical Hospital of the Russian Academy of Sciences | 2015-05-01 |
| Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers (NCT02392468) | Boehringer Ingelheim | 2015-04-15 |
| The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia (NCT05172687) | Columbia University | 2015-04-01 |
| Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD (NCT02444637) | National Neuroscience Institute | 2015-04-01 |
| ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program (NCT02746484) | Fondazione Don Carlo Gnocchi ETS | 2015-04-01 |
| Effects of Visual Arts Training on Dementia (NCT02432222) | York University | 2015-04-01 |
| Overuse of Antidepressant in Patients With Alzheimer Disease (NCT02529436) | Assistance Publique - Hôpitaux de Paris | 2015-04-01 |
| PatientSpot Formerly Known as ArthritisPower (NCT03840928) | Global Healthy Living Foundation | 2015-04-01 |
| Care Ecosystem: Navigating Patients and Families Through Stages of Care (NCT02213458) | University of California, San Francisco | 2015-03-20 |
| Care Ecosystem: Navigating Patients and Families Through Stages of Care, Extension Trial (NCT04287738) | University of California, San Francisco | 2015-03-20 |
| F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E) (NCT02414282) | Tammie L. S. Benzinger, MD, PhD | 2015-03-01 |
| Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease (NCT02388152) | H. Lundbeck A/S | 2015-03-01 |
| A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease (NCT02353598) | Genentech, Inc. | 2015-02-26 |
| Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients (NCT02840045) | Centre Hospitalier Universitaire de Besancon | 2015-02-20 |
| The Comparative Effectiveness Dementia & Alzheimer's Registry (NCT03687710) | Weill Medical College of Cornell University | 2015-02-16 |
| Sound Estimation and Accuracy Task (NCT02271685) | Carnegie Mellon University | 2015-02-01 |
| Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study (NCT02362880) | Judit Pich Martínez | 2015-02-01 |
| BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. (NCT02337907) | Boehringer Ingelheim | 2015-01-21 |
| Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo (NCT02240693) | Boehringer Ingelheim | 2015-01-15 |
| Identification of Predictors for Early Cognitive Decline in Men (NCT03290040) | Rigshospitalet, Denmark | 2015-01-01 |
| Safety and Efficacy of Nabilone in Alzheimer's Disease (NCT02351882) | Sunnybrook Health Sciences Centre | 2015-01-01 |
| I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers (NCT02323217) | Imperial College London | 2015-01-01 |
| LIWA for Treatment of Alzheimer Patients (NCT02204969) | American Society Of Thermalism And Climatology Inc | 2015-01-01 |
| Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function (NCT02340195) | H. Lundbeck A/S | 2015-01-01 |
| Deep Brain Stimulation in Alzheimer's Disease: Biomarkers and Dose Optimization (NCT04856072) | University Health Network, Toronto | 2014-12-19 |
| Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research (NCT02351388) | National Center of Neurology and Psychiatry, Japan | 2014-12-01 |
| P75NTR, Diagnostic Biomarker for Alzheimer's Disease: Quantification Study in Cerebrospinal Fluid (NCT02946710) | University Hospital, Toulouse | 2014-12-01 |
| Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease (NCT02800395) | Hospices Civils de Lyon | 2014-12-01 |
| Memory Problems Perceptions Among Patients and Accompaniers During Diagnosis Process : (NCT02299154) | Central Hospital, Nancy, France | 2014-12-01 |
| A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease (NCT02323334) | Eli Lilly and Company | 2014-12-01 |
| Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease (NCT02322021) | Eisai Inc. | 2014-11-26 |
| Agitation and Aggressivity in Alzheimer's Disease Patients: A Cohort Study (NCT03554226) | University Hospital, Toulouse | 2014-11-01 |
| F 18 T807 Tau PET Imaging of Alzheimer's Disease (NCT02414347) | Tammie L. S. Benzinger, MD, PhD | 2014-10-23 |
| LESCOD: "Lewy Body Screening in Cognitive Disorders" (NCT02263287) | Nantes University Hospital | 2014-10-01 |
| Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease (NCT04468347) | Avid Radiopharmaceuticals | 2014-10-01 |
| Hearing Instruments in Alzheimer's Disease (NCT02294513) | Phonak AG, Switzerland | 2014-10-01 |
| Application of Amyloid PET in Cerebral Amyloid Angiopathy (NCT03542656) | National Taiwan University Hospital | 2014-09-11 |